The Billion-Dollar Question: Using Drug Patent Data as Your Crystal Ball in Pharma M&A Due Diligence
In the high-stakes world of pharmaceutical mergers and acquisitions, the difference between a successful deal and a costly misstep often hinges on one critical factor: deep, data-driven insight into a drug’s patent landscape. Yet, many dealmakers still…